Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients

J Clin Invest. 2011 Jun;121(6):2350-60. doi: 10.1172/JCI46102. Epub 2011 May 9.

Abstract

In chronic viral infections, CD8⁺ T cells become functionally deficient and display multiple molecular alterations. In contrast, only little is known of self- and tumor-specific CD8⁺ T cells from mice and humans. Here we determined molecular profiles of tumor-specific CD8⁺ T cells from melanoma patients. In peripheral blood from patients vaccinated with CpG and the melanoma antigen Melan-A/MART-1 peptide, we found functional effector T cell populations, with only small but nevertheless significant differences in T cells specific for persistent herpesviruses (EBV and CMV). In contrast, Melan-A/MART-1-specific T cells isolated from metastases from patients with melanoma expressed a large variety of genes associated with T cell exhaustion. The identified exhaustion profile revealed extended molecular alterations. Our data demonstrate a remarkable coexistence of effector cells in circulation and exhausted cells in the tumor environment. Functional T cell impairment is mediated by inhibitory receptors and further molecular pathways, which represent potential targets for cancer therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / pathology*
  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use
  • CpG Islands / immunology*
  • Cytomegalovirus / immunology
  • Cytomegalovirus Infections / immunology
  • Epstein-Barr Virus Infections / immunology
  • Gene Expression Profiling*
  • Herpesvirus 4, Human / immunology
  • Humans
  • Lymphocytes, Tumor-Infiltrating / immunology
  • MART-1 Antigen / immunology*
  • Melanoma / immunology*
  • Melanoma / secondary*
  • Melanoma / therapy
  • Molecular Sequence Data
  • Receptors, Immunologic / biosynthesis
  • Receptors, Immunologic / genetics
  • T-Cell Antigen Receptor Specificity
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism
  • T-Lymphocyte Subsets / pathology*
  • Vaccination
  • Virus Latency / immunology

Substances

  • Cancer Vaccines
  • MART-1 Antigen
  • MLANA protein, human
  • Receptors, Immunologic

Associated data

  • GEO/GSE24536